 | • レポートコード：QYR9ST01558 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の免疫療法市場について調査・分析し、以下の構成でお届け致します。免疫療法の種類別には、モノクローナル抗体、治療ワクチン、チェックポイント阻害剤、非特異的免疫療法に、用途別には、腫瘍学、炎症、中枢神経系、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別免疫療法売上データ ・地域別免疫療法市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別免疫療法市場規模：モノクローナル抗体、治療ワクチン、チェックポイント阻害剤、非特異的免疫療法 ・用途別免疫療法市場規模：腫瘍学、炎症、中枢神経系、その他 ・主要メーカーの企業情報：Abbvie、Amgen, Inc.、Biogen、Bristol-Myers Squibb、Celgene、Johnson & Johnson、Merck、Novartis、Pfizer、Roche ・免疫療法の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy.The global Immunotherapy market is valued at 106900 million US$ in 2018 and will reach 179100 million US$ by the end of 2025, growing at a CAGR of 6.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Immunotherapy market based on company, product type, end user and key regions.
This report studies the global market size of Immunotherapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Immunotherapy in these regions.
This research report categorizes the global Immunotherapy market by top players/brands, region, type and end user. This report also studies the global Immunotherapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Market size by Product
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Market size by End User
Oncology
Inflammation
Central Nervous System
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Immunotherapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Immunotherapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Immunotherapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Immunotherapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Immunotherapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Immunotherapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Immunotherapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Immunotherapy Market Size Growth Rate by Product
1.4.2 Monoclonal Antibodies
1.4.3 Therapeutic Vaccines
1.4.4 Checkpoint Inhibitors
1.4.5 Non-Specific Immunotherapy
1.5 Market by End User
1.5.1 Global Immunotherapy Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Inflammation
1.5.4 Central Nervous System
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunotherapy Market Size
2.1.1 Global Immunotherapy Revenue 2014-2025
2.1.2 Global Immunotherapy Sales 2014-2025
2.2 Immunotherapy Growth Rate by Regions
2.2.1 Global Immunotherapy Sales by Regions
2.2.2 Global Immunotherapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Immunotherapy Sales by Manufacturers
3.1.1 Immunotherapy Sales by Manufacturers
3.1.2 Immunotherapy Sales Market Share by Manufacturers
3.1.3 Global Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 Immunotherapy Revenue by Manufacturers
3.2.1 Immunotherapy Revenue by Manufacturers (2014-2019)
3.2.2 Immunotherapy Revenue Share by Manufacturers (2014-2019)
3.3 Immunotherapy Price by Manufacturers
3.4 Immunotherapy Manufacturing Base Distribution, Product Types
3.4.1 Immunotherapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunotherapy Product Type
3.4.3 Date of International Manufacturers Enter into Immunotherapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Immunotherapy Sales by Product
4.2 Global Immunotherapy Revenue by Product
4.3 Immunotherapy Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Immunotherapy Breakdown Data by End User
6 North America
6.1 North America Immunotherapy by Countries
6.1.1 North America Immunotherapy Sales by Countries
6.1.2 North America Immunotherapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Immunotherapy by Product
6.3 North America Immunotherapy by End User
7 Europe
7.1 Europe Immunotherapy by Countries
7.1.1 Europe Immunotherapy Sales by Countries
7.1.2 Europe Immunotherapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immunotherapy by Product
7.3 Europe Immunotherapy by End User
8 Asia Pacific
8.1 Asia Pacific Immunotherapy by Countries
8.1.1 Asia Pacific Immunotherapy Sales by Countries
8.1.2 Asia Pacific Immunotherapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Immunotherapy by Product
8.3 Asia Pacific Immunotherapy by End User
9 Central & South America
9.1 Central & South America Immunotherapy by Countries
9.1.1 Central & South America Immunotherapy Sales by Countries
9.1.2 Central & South America Immunotherapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Immunotherapy by Product
9.3 Central & South America Immunotherapy by End User
10 Middle East and Africa
10.1 Middle East and Africa Immunotherapy by Countries
10.1.1 Middle East and Africa Immunotherapy Sales by Countries
10.1.2 Middle East and Africa Immunotherapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Immunotherapy by Product
10.3 Middle East and Africa Immunotherapy by End User
11 Company Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Company Business Overview
11.1.3 Abbvie Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbvie Immunotherapy Products Offered
11.1.5 Abbvie Recent Development
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Company Details
11.2.2 Company Business Overview
11.2.3 Amgen, Inc. Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Amgen, Inc. Immunotherapy Products Offered
11.2.5 Amgen, Inc. Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Company Business Overview
11.3.3 Biogen Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Biogen Immunotherapy Products Offered
11.3.5 Biogen Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Company Business Overview
11.4.3 Bristol-Myers Squibb Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bristol-Myers Squibb Immunotherapy Products Offered
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Company Business Overview
11.5.3 Celgene Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Celgene Immunotherapy Products Offered
11.5.5 Celgene Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Company Business Overview
11.6.3 Johnson & Johnson Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Johnson & Johnson Immunotherapy Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Company Business Overview
11.7.3 Merck Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck Immunotherapy Products Offered
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novartis Immunotherapy Products Offered
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Business Overview
11.9.3 Pfizer Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pfizer Immunotherapy Products Offered
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Company Business Overview
11.10.3 Roche Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Roche Immunotherapy Products Offered
11.10.5 Roche Recent Development
12 Future Forecast
12.1 Immunotherapy Market Forecast by Regions
12.1.1 Global Immunotherapy Sales Forecast by Regions 2019-2025
12.1.2 Global Immunotherapy Revenue Forecast by Regions 2019-2025
12.2 Immunotherapy Market Forecast by Product
12.2.1 Global Immunotherapy Sales Forecast by Product 2019-2025
12.2.2 Global Immunotherapy Revenue Forecast by Product 2019-2025
12.3 Immunotherapy Market Forecast by End User
12.4 North America Immunotherapy Forecast
12.5 Europe Immunotherapy Forecast
12.6 Asia Pacific Immunotherapy Forecast
12.7 Central & South America Immunotherapy Forecast
12.8 Middle East and Africa Immunotherapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunotherapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Immunotherapy Product Picture
Table Immunotherapy Market Segments
Table Key Manufacturers Immunotherapy Covered
Table Global Immunotherapy Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Immunotherapy Sales Market Share by Product 2014-2025
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Therapeutic Vaccines Product Picture
Table Major Manufacturers of Therapeutic Vaccines
Figure Checkpoint Inhibitors Product Picture
Table Major Manufacturers of Checkpoint Inhibitors
Figure Non-Specific Immunotherapy Product Picture
Table Major Manufacturers of Non-Specific Immunotherapy
Table Global Immunotherapy Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oncology
Figure Inflammation
Figure Central Nervous System
Figure Others
Figure Immunotherapy Report Years Considered
Figure Global Immunotherapy Market Size 2014-2025 (Million US$)
Figure Global Immunotherapy Sales 2014-2025 (K Units)
Table Global Immunotherapy Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Immunotherapy Sales by Regions 2014-2019 (K Units)
Table Global Immunotherapy Sales Market Share by Regions 2014-2019
Figure Global Immunotherapy Sales Market Share by Regions 2014-2019
Figure 2018 Global Immunotherapy Sales Market Share by Regions
Table Global Immunotherapy Revenue by Regions 2014-2019 (Million US$)
Table Global Immunotherapy Revenue Market Share by Regions 2014-2019
Figure Global Immunotherapy Revenue Market Share by Regions 2014-2019
Figure 2018 Global Immunotherapy Revenue Market Share by Regions
Table Global Immunotherapy Sales by Manufacturers (2014-2019) (K Units)
Table Global Immunotherapy Sales Share by Manufacturers (2014-2019)
Figure Global Immunotherapy Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Immunotherapy Revenue by Manufacturers (2014-2019) (Million USD)
Table Immunotherapy Revenue Share by Manufacturers (2014-2019)
Figure Immunotherapy Value Share by Manufacturers in 2018
Table Key Manufacturers Immunotherapy Price (2014-2019) (USD/Unit)
Table Immunotherapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Immunotherapy Product Type
Table Date of International Manufacturers Enter into Immunotherapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Immunotherapy Sales by Product (2014-2019) (K Units)
Table Global Immunotherapy Sales Share by Product (2014-2019)
Figure Global Immunotherapy Sales Market Share by Product (2014-2019)
Figure Global Immunotherapy Sales Market Share by Product in 2018
Table Global Immunotherapy Revenue by Product (2014-2019) (Million US$)
Table Global Immunotherapy Revenue Share by Product (2014-2019)
Figure Global Immunotherapy Revenue Market Share by Product (2014-2019)
Figure Global Immunotherapy Revenue Market Share by Product in 2018
Table Immunotherapy Price by Product 2014-2019 (USD/Unit)
Table Global Immunotherapy Sales by End User (2014-2019) (K Units)
Table Global Immunotherapy Sales Share by End User (2014-2019)
Figure Global Sales Immunotherapy Market Share by End User (2014-2019)
Figure Global Sales Immunotherapy Market Share by End User in 2018
Figure North America Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure North America Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table North America Immunotherapy Sales by Countries (2014-2019) (K Units)
Table North America Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 North America Immunotherapy Sales Market Share by Countries
Table North America Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table North America Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Immunotherapy Revenue Market Share by Countries
Figure United States Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure United States Immunotherapy Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Canada Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table North America Immunotherapy Sales by Product (2014-2019) (K Units)
Table North America Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 North America Immunotherapy Market Share by Product
Table North America Immunotherapy Sales by End User (2014-2019) (K Units)
Table North America Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 North America Immunotherapy Market Share by End User
Figure Europe Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure Europe Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Immunotherapy Sales by Countries (2014-2019) (K Units)
Table Europe Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Immunotherapy Sales Market Share by Countries
Table Europe Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table Europe Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Immunotherapy Revenue Market Share by Countries
Figure Germany Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Germany Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure France Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure France Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure UK Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Italy Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Russia Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Immunotherapy Sales by Product (2014-2019) (K Units)
Table Europe Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 Europe Immunotherapy Market Share by Product
Table Europe Immunotherapy Sales by End User (2014-2019) (K Units)
Table Europe Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 Europe Immunotherapy Market Share by End User
Figure Asia Pacific Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Immunotherapy Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Immunotherapy Sales Market Share by Countries
Table Asia Pacific Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Immunotherapy Revenue Market Share by Countries
Figure China Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure China Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Japan Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Korea Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure India Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure India Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Australia Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Immunotherapy Sales by Product (2014-2019) (K Units)
Table Asia Pacific Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Immunotherapy Market Share by Product
Table Asia Pacific Immunotherapy Sales by End User (2014-2019) (K Units)
Table Asia Pacific Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Immunotherapy Market Share by End User
Figure Central & South America Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Immunotherapy Sales by Countries (2014-2019) (K Units)
Table Central & South America Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Immunotherapy Sales Market Share by Countries
Table Central & South America Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Immunotherapy Revenue Market Share by Countries
Figure Brazil Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Immunotherapy Sales by Product (2014-2019) (K Units)
Table Central & South America Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Immunotherapy Market Share by Product
Table Central & South America Immunotherapy Sales by End User (2014-2019) (K Units)
Table Central & South America Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Immunotherapy Market Share by End User
Figure Middle East and Africa Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Immunotherapy Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Immunotherapy Sales Market Share by Countries
Table Middle East and Africa Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Immunotherapy Revenue Market Share by Countries
Figure GCC Countries Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Immunotherapy Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Immunotherapy Market Share by Product
Table Middle East and Africa Immunotherapy Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Immunotherapy Market Share by End User
Table Abbvie Company Details
Table Abbvie Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbvie Recent Development
Table Amgen, Inc. Company Details
Table Amgen, Inc. Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen, Inc. Recent Development
Table Biogen Company Details
Table Biogen Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celgene Company Details
Table Celgene Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celgene Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Global Immunotherapy Sales Forecast by Regions 2019-2025 (K Units)
Table Global Immunotherapy Sales Market Share Forecast by Regions 2019-2025
Table Global Immunotherapy Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Immunotherapy Revenue Market Share Forecast by Regions 2019-2025
Table Global Immunotherapy Sales Forecast by Product 2019-2025 (K Units)
Table Global Immunotherapy Sales Market Share Forecast by Product 2019-2025
Table Global Immunotherapy Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Immunotherapy Revenue Market Share Forecast by Product 2019-2025
Table Global Immunotherapy Sales Forecast by End User 2019-2025 (K Units)
Table Global Immunotherapy Sales Market Share Forecast by End User 2019-2025
Figure North America Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Immunotherapy Value Chain
Table Immunotherapy Customers List
Table Immunotherapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
免疫療法薬の世界市場：市場規模・現状・予測 Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.North America is expected to account for largest share in the i…- 腫瘍溶解性ウイルス免疫療法の世界市場：市場規模・現状・予測 Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus …
- 組換え治療用抗体及びタンパク質の世界市場：インサイト・予測 Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- 免疫腫瘍学の世界市場：市場規模・現状・予測 Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.In 2018, the global Immuno-Oncology market size was xx million US$ and it is expected t…